OXNARD, Calif., May 08, 2017 -- Clean Diesel Technologies, Inc. (Nasdaq:CDTI) (“CDTi” or “the Company”), a leader in advanced emission control technology, announced it will report its first quarter 2017 financial results after the market closes on Monday, May 15, 2017. CDTi will hold a conference call that same day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its results and answer questions.
To participate in the conference call, please dial +1 (877) 303-9240 and international participants should dial +1 (760) 666-3571. The conference code is 15954609. The conference call will be webcast live on the CDTi website at www.cdti.com under the "Investor Relations" section. To listen to the live webcast, participants should visit the site at least 15 minutes prior to the conference to download any required streaming media software. An archived recording of the conference call will be available on the CDTi website for 30 days. You may also access a telephone replay for two business days following the conclusion of the call by dialing +1 (855) 859-2056 or +1 (404) 537-3406 if dialing in internationally. The passcode is 15954609.
About CDTi
CDTi develops advanced materials technology for the emissions control market. CDTi's proprietary technologies provide high-value sustainable solutions to reduce hazardous emissions, increase energy efficiency and lower the carbon intensity of on- and off-road combustion engine systems. With a continuing focus on innovation-driven commercialization and global expansion, CDTi's breakthrough Powder-to-Coat (P2C™) technology exploits the Company's high-performance, advanced low-platinum group metal (PGM) emission reduction catalysts. Key technology platforms include Mixed Phase Catalyst (MPC®), Base Metal Activated Rhodium Support (BMARS™), Synergized PGM (SPGM™), Zero PGM (ZPGM™) and Spinel™. For more information, please visit www.cdti.com.
Contact Information:
Becky Herrick or Cathy Mattison
LHA (IR Agency)
+1 (415) 433 3777
[email protected]
[email protected]


Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal
CN Energy Group Inc. Stock Slides After Nasdaq Delisting Notice Over Bid Price Rule
Nintendo Stock Jumps as Switch 2 Becomes Best-Selling Console in the U.S. in 2025
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors 



